Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI abnormal patterns of lumbar paraspinal muscles in patients with amyotrophic lateral sclerosis and lumbosacral radiculopathy: a comparative study.

Frontiers in neurology·2026
Same author

Semaphorins: from CD8⁺ T cells to cancer immunotherapy.

Biomarker research·2026
Same author

Proteomic Landscape of Sweat Glands in Neuronal Intranuclear Inclusion Disease Reveals a Pathogenic Triad of Abnormal Autophagy, Mitochondrial Dysfunction, and a Failed Oxidative Stress Response.

Journal of neurochemistry·2026
Same author

Designed Versus Achieved 3D Mandibular Teeth Movements and Influencing Factors After First Premolar Extraction With Invisalign: A New Digital Root Model.

Orthodontics & craniofacial research·2025
Same author

Identification of m5C-related genes and subclusters in recurrent pregnancy loss.

Journal of assisted reproduction and genetics·2025
Same author

Preliminary Observations on the Efficacy of Efgartigimod Therapy in Autoimmune Nodopathy.

European journal of neurology·2025
Same journal

MT-MRI for detection of renal interstitial fibrosis in renovascular disease.

Scientific reports·2026
Same journal

Detection of underground objects from GPR data using a lightweight YOLO-based approach.

Scientific reports·2026
Same journal

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab.

Scientific reports·2026
Same journal

Water balance components in a dry-seeded rice-wheat system: Untangling the effects of tillage and mulching practices.

Scientific reports·2026
Same journal

Topological approaches to quantum tensor train compression via ZX-calculus and SVD.

Scientific reports·2026
Same journal

determinants of flood impacts and adaptive capacity among market vendors in Walukuba-Masese, Jinja city, Uganda.

Scientific reports·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

24.1K

RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.

Li Yan1,2, Yaomin Chen2, Wubo Li3

  • 1Department of Pharmacology, School of Medicine, Jinan University, Guangzhou 510632, China.

Scientific Reports
|January 7, 2016
PubMed
Summary
This summary is machine-generated.

The human homolog RPS23RG1 counteracts Alzheimer's disease (AD) by promoting synaptic plasticity and reducing amyloid-beta production. Lower RPS23RG1 levels in AD brains suggest its protective role against cognitive decline.

More Related Videos

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
09:52

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

11.2K
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

19.4K

Related Experiment Videos

Last Updated: Mar 27, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

24.1K
Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
09:52

Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System

Published on: December 28, 2017

11.2K
Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

19.4K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia, characterized by amyloid-beta plaques, tau tangles, and synaptic loss.
  • The mouse gene Rps23rg1 reduces amyloid-beta production and tau phosphorylation, suggesting a potential therapeutic target.

Purpose of the Study:

  • Identify the human homolog of Rps23rg1 and investigate its role in Alzheimer's disease pathogenesis.
  • Determine if RPS23RG1 can counteract amyloid-beta oligomer-induced cognitive deficits and synaptic dysfunction.

Main Methods:

  • Identified human RPS23RG1 and analyzed its expression in AD patient brains.
  • Investigated RPS23RG1 interaction with adenylate cyclase, PKA/CREB, and GSK-3 signaling pathways.
  • Assessed RPS23RG1's effect on synaptic plasticity and amyloid-beta oligomer-induced deficits in primary neurons and transgenic mice.

Main Results:

  • Human RPS23RG1 was identified and found at lower levels in AD brains.
  • RPS23RG1 activates PKA/CREB and inhibits GSK-3, promoting synaptic plasticity.
  • RPS23RG1 overexpression in mice prevented amyloid-beta oligomer-induced synaptic deficits and cognitive impairment.

Conclusions:

  • RPS23RG1 plays a crucial role in maintaining synaptic function and counteracting Alzheimer's disease pathology.
  • RPS23RG1 represents a potential therapeutic target for Alzheimer's disease treatment.